SE434119B - Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-((2,6-diklorofenyl)amino)-2-imidazolin - Google Patents

Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-((2,6-diklorofenyl)amino)-2-imidazolin

Info

Publication number
SE434119B
SE434119B SE7806469A SE7806469A SE434119B SE 434119 B SE434119 B SE 434119B SE 7806469 A SE7806469 A SE 7806469A SE 7806469 A SE7806469 A SE 7806469A SE 434119 B SE434119 B SE 434119B
Authority
SE
Sweden
Prior art keywords
clonidine
phenoxybenzamine
antihypertensive
dichlorophenyl
acid
Prior art date
Application number
SE7806469A
Other languages
English (en)
Swedish (sv)
Other versions
SE7806469L (sv
Inventor
A Sjoerdsma
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE7806469L publication Critical patent/SE7806469L/xx
Publication of SE434119B publication Critical patent/SE434119B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7806469A 1977-05-31 1978-06-01 Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-((2,6-diklorofenyl)amino)-2-imidazolin SE434119B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/802,027 US4215130A (en) 1977-05-31 1977-05-31 Antihypertensive compositions of N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine and N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine

Publications (2)

Publication Number Publication Date
SE7806469L SE7806469L (sv) 1979-12-02
SE434119B true SE434119B (sv) 1984-07-09

Family

ID=25182653

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7806469A SE434119B (sv) 1977-05-31 1978-06-01 Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-((2,6-diklorofenyl)amino)-2-imidazolin

Country Status (14)

Country Link
US (1) US4215130A (ja)
AU (1) AU515368B2 (ja)
BE (1) BE867489A (ja)
CA (1) CA1110170A (ja)
DE (1) DE2823267A1 (ja)
FR (1) FR2392669A1 (ja)
GB (1) GB1573595A (ja)
IE (1) IE46709B1 (ja)
IL (1) IL54505A0 (ja)
NL (1) NL189649C (ja)
NZ (1) NZ186893A (ja)
PH (1) PH13566A (ja)
SE (1) SE434119B (ja)
ZA (1) ZA781920B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603141A (en) * 1984-11-30 1986-07-29 Giles Thomas D Oral clonidine treatment of congestive heart failure
WO1988005789A1 (en) * 1987-01-29 1988-08-11 Biotechnology Australia Pty. Ltd. Isolation of single chain proteins with fsh suppressing activity from follicular fluid
US5369095A (en) * 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2599000A (en) * 1950-09-02 1952-06-03 Smith Kline French Lab Nu, nu-disubstituted-beta-halo-alkylamines
US3236857A (en) * 1961-10-09 1966-02-22 Boehringer Sohn Ingelheim 2-(phenyl-amino)-1, 3-diazacyclopentene-(2) substitution products
US4022893A (en) * 1975-01-24 1977-05-10 Moyer John H Treatment for hypertension

Also Published As

Publication number Publication date
US4215130A (en) 1980-07-29
AU3487778A (en) 1979-10-11
NL189649B (nl) 1993-01-18
IL54505A0 (en) 1978-07-31
IE780669L (en) 1978-11-30
NZ186893A (en) 1980-04-28
FR2392669B1 (ja) 1980-04-11
IE46709B1 (en) 1983-08-24
GB1573595A (en) 1980-08-28
DE2823267A1 (de) 1978-12-14
CA1110170A (en) 1981-10-06
ZA781920B (en) 1979-03-28
DE2823267C2 (ja) 1987-12-03
BE867489A (fr) 1978-09-18
NL7804523A (nl) 1978-12-04
NL189649C (nl) 1993-06-16
AU515368B2 (en) 1981-04-02
FR2392669A1 (fr) 1978-12-29
PH13566A (en) 1980-06-26
SE7806469L (sv) 1979-12-02

Similar Documents

Publication Publication Date Title
NL7909307A (nl) Farmaceutisch preparaat voor het beinvloeden van het centrale zenuwstelsel en werkwijze voor het beinvloeden van het centrale zenuwstelsel.
US20080312163A1 (en) Treatment of pulmonary hypertension with carbonic anhydrase inhibitors
CA2870123C (en) Orally available pharmaceutical formulation suitable for improved management of movement disorders
CN106074445B (zh) 包衣药物球状体及其制备消除或减少病症的药物的用途
PL215235B1 (pl) Kompozycja farmaceutyczna zawierajaca cylobradyne
EP0526540B1 (en) Use of 5-ht4-receptor antagonists in the treatment of atrial fibrillation, including the prevention of stroke
DE60030654T2 (de) Verwendung von Lasofoxifen
EP0981340B1 (fr) Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique
SE434119B (sv) Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-((2,6-diklorofenyl)amino)-2-imidazolin
US4189492A (en) Antihypertensive compositions of 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxy-ethyl)benzenemethanamine
US4794111A (en) Dihydropyridine preparations containing β-blockers
SE427083B (sv) Antihypertensivt preparat i enhetsdosform, innehallande bl a 2-(1-(2,6-diklorofenoxi)etyl)-4,5-dihydro-1h-imidazol
CZ227092A3 (en) Pharmaceutical composition used in high blood pressure therapy
SK19192000A3 (sk) Použitie paroxetínu alebo jeho farmaceuticky prijateľnej soli alebo solvátu na podporu odvykania od fajčenia alebo na zníženie alebo prevenciu relapsu fajčenia
JPH04279524A (ja) 脳血管疾患治療剤
FR2915100A1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxalide pour le traitement des desordres moteurs lies a la maladie de parkinson
AU5549494A (en) Methods and compositions of (+) doxazosin for the treatment of hypertension
WO2008064595A1 (fr) 5-[(2r)-[2-[2-[2-(2,2,2-trifluoroéthoxy)phénoxy]éthyl]amino]propyl]-2-méthoxybenzenesulfonamide
CZ420099A3 (cs) Léčivo pro léčbu izolované systolické hypertense
WO1994009782A1 (en) Methods and compositions of (-) doxazosin for the treatment of hypertension

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7806469-8

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7806469-8

Format of ref document f/p: F